TAO Synergies Inc banner

TAO Synergies Inc
NASDAQ:TAOX

Watchlist Manager
TAO Synergies Inc Logo
TAO Synergies Inc
NASDAQ:TAOX
Watchlist
Price: 3.72 USD -1.06% Market Closed
Market Cap: $26.5m

TAO Synergies Inc
Investor Relations

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2020-12-07. The firm's differentiated cryptocurrency treasury strategy is centered exclusively on the acquisition of TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Contacts

Address
NEW YORK
New York City
1185 Avenue Of The Americas, 3Rd Floor
Contacts